cbdMD, Inc. (YCBD)
NYSEAMERICAN: YCBD · Real-Time Price · USD
0.7201
-0.0298 (-3.97%)
At close: Sep 4, 2025, 4:00 PM
0.7020
-0.0181 (-2.51%)
Pre-market: Sep 5, 2025, 8:15 AM EDT

cbdMD Statistics

Total Valuation

cbdMD has a market cap or net worth of $6.42 million. The enterprise value is $6.32 million.

Market Cap6.42M
Enterprise Value 6.32M

Important Dates

The last earnings date was Thursday, August 14, 2025, after market close.

Earnings Date Aug 14, 2025
Ex-Dividend Date n/a

Share Statistics

cbdMD has 8.91 million shares outstanding. The number of shares has increased by 510.60% in one year.

Current Share Class 8.91M
Shares Outstanding 8.91M
Shares Change (YoY) +510.60%
Shares Change (QoQ) +642.97%
Owned by Insiders (%) 1.74%
Owned by Institutions (%) 7.27%
Float 8.76M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.08
Forward PS 0.32
PB Ratio 1.05
P/TBV Ratio 1.69
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.33
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.16.

Current Ratio 1.56
Quick Ratio 0.57
Debt / Equity 0.16
Debt / EBITDA 0.51
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -33.13% and return on invested capital (ROIC) is -15.78%.

Return on Equity (ROE) -33.13%
Return on Assets (ROA) -9.44%
Return on Invested Capital (ROIC) -15.78%
Return on Capital Employed (ROCE) -28.41%
Revenue Per Employee $453,002
Profits Per Employee -$115,494
Employee Count42
Asset Turnover 1.60
Inventory Turnover 2.28

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -84.29% in the last 52 weeks. The beta is 2.30, so cbdMD's price volatility has been higher than the market average.

Beta (5Y) 2.30
52-Week Price Change -84.29%
50-Day Moving Average 0.85
200-Day Moving Average 2.21
Relative Strength Index (RSI) 43.03
Average Volume (20 Days) 148,132

Short Selling Information

The latest short interest is 67,802, so 0.76% of the outstanding shares have been sold short.

Short Interest 67,802
Short Previous Month 41,796
Short % of Shares Out 0.76%
Short % of Float 0.77%
Short Ratio (days to cover) 0.74

Income Statement

In the last 12 months, cbdMD had revenue of $19.03 million and -$4.85 million in losses. Loss per share was -$2.41.

Revenue19.03M
Gross Profit 11.64M
Operating Income -1.79M
Pretax Income -158,723
Net Income -4.85M
EBITDA -641,470
EBIT -1.79M
Loss Per Share -$2.41
Full Income Statement

Balance Sheet

The company has $1.06 million in cash and $962,738 in debt, giving a net cash position of $96,821 or $0.01 per share.

Cash & Cash Equivalents 1.06M
Total Debt 962,738
Net Cash 96,821
Net Cash Per Share $0.01
Equity (Book Value) 6.11M
Book Value Per Share 0.69
Working Capital 2.01M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$1.04 million and capital expenditures -$191,368, giving a free cash flow of -$1.24 million.

Operating Cash Flow -1.04M
Capital Expenditures -191,368
Free Cash Flow -1.24M
FCF Per Share -$0.14
Full Cash Flow Statement

Margins

Gross margin is 61.20%, with operating and profit margins of -9.43% and -7.96%.

Gross Margin 61.20%
Operating Margin -9.43%
Pretax Margin -7.96%
Profit Margin -7.96%
EBITDA Margin -3.37%
EBIT Margin -9.43%
FCF Margin n/a

Dividends & Yields

cbdMD does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -510.60%
Shareholder Yield -510.60%
Earnings Yield -75.58%
FCF Yield -19.25%

Analyst Forecast

The average price target for cbdMD is $2.00, which is 177.74% higher than the current price. The consensus rating is "Strong Buy".

Price Target $2.00
Price Target Difference 177.74%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on May 7, 2025. It was a reverse split with a ratio of 1:8.

Last Split Date May 7, 2025
Split Type Reverse
Split Ratio 1:8

Scores

cbdMD has an Altman Z-Score of -23.29 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -23.29
Piotroski F-Score 3